262 results
Page 5 of 14
PRE 14A
uon5slqfahj 00lz02
11 Mar 19
Preliminary proxy
5:07pm
8-K
EX-99.1
xzoortv icy1lgckvo
7 Feb 19
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Recent Period Activity
4:15pm
8-K
EX-99.1
cueub e85s1h
15 Jan 19
Entry into a Material Definitive Agreement
5:19pm
424B5
kbgayej
15 Jan 19
Prospectus supplement for primary offering
5:14pm
424B5
zt0kp11p5rt
14 Jan 19
Prospectus supplement for primary offering
4:41pm
8-K
EX-99.1
1c0z6r jrol
7 Jan 19
Results of Operations and Financial Condition
8:11am
8-K
EX-99.1
nnpkuar2siojh
7 Nov 18
Alnylam Pharmaceuticals Reports Third Quarter 2018 Financial Results and Highlights Recent Period Activity
8:16am
8-K
EX-99.1
8pu0kx3dr62qyflb6vef
10 Aug 18
ONPATTROâ„¢ (patisiran) for the Treatment of the Polyneuropathy of Hereditary
3:45pm
8-K
EX-99.1
hoi4u40
2 Aug 18
Alnylam Pharmaceuticals Reports Second Quarter 2018 Financial Results and Highlights Recent Period Activity
8:15am
8-K
EX-99.1
uz38yk pl1h2l
3 May 18
Alnylam Pharmaceuticals Reports First Quarter 2018 Financial Results and Highlights Recent Period Activity
4:15pm
8-K
EX-99.1
hk4x4
20 Apr 18
Alnylam Reaches Settlement Agreement with Dicerna Pharmaceuticals Resolving Trade
12:00am